Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (401-410 of 568) with videos related to

Pageof 57
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trialsDerrick W Crook, A Sarah Walker, Yin Kean, et al.
The Australian and New Zealand Journal of Psychiatry|November 17, 2020
Implementing a systems approach to suicide prevention in a mental health service using the Zero Suicide FrameworkKathryn Turner, Jerneja Sveticic, Alice Almeida-Crasto, et al.
BMC Medicine|March 24, 2016
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapyAngela M Crook, Anna Turkova, Victor Musiime, et al.
The Lancet. Global Health|February 18, 2022
Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trialElizabeth C George, Sophie Uyoga, Bridon M'baya, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015David W Eyre, Robert Shaw, Helen Adams, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Awareness of Appropriate Antibiotic Use in Primary Care for Influenza-Like Illness: Evidence of Improvement from UK Population-Based SurveysKoen B Pouwels, Laurence S J Roope, James Buchanan, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
The Lancet. Infectious Diseases|November 8, 2017
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialJames G Hakim, Jennifer Thompson, Cissy Kityo, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 10, 2025
Reimagining Dementia Care: A Complex Intervention Systematic Review on Optimising Social Prescribing (SP) for Carers of People Living With Dementia (PLWD) in the United KingdomJessica Marshall, Evie Papavasiliou, Louise Allan, et al.
Pageof 57

Showing results (401-410 of 568) with videos related to

Sort By:
Pageof 57
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trialsDerrick W Crook, A Sarah Walker, Yin Kean, et al.
The Australian and New Zealand Journal of Psychiatry|November 17, 2020
Implementing a systems approach to suicide prevention in a mental health service using the Zero Suicide FrameworkKathryn Turner, Jerneja Sveticic, Alice Almeida-Crasto, et al.
BMC Medicine|March 24, 2016
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapyAngela M Crook, Anna Turkova, Victor Musiime, et al.
The Lancet. Global Health|February 18, 2022
Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trialElizabeth C George, Sophie Uyoga, Bridon M'baya, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015David W Eyre, Robert Shaw, Helen Adams, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Awareness of Appropriate Antibiotic Use in Primary Care for Influenza-Like Illness: Evidence of Improvement from UK Population-Based SurveysKoen B Pouwels, Laurence S J Roope, James Buchanan, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Plos Medicine|November 15, 2017
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trialAlexander J Szubert, Andrew J Prendergast, Moira J Spyer, et al.
The Lancet. Infectious Diseases|November 8, 2017
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialJames G Hakim, Jennifer Thompson, Cissy Kityo, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 10, 2025
Reimagining Dementia Care: A Complex Intervention Systematic Review on Optimising Social Prescribing (SP) for Carers of People Living With Dementia (PLWD) in the United KingdomJessica Marshall, Evie Papavasiliou, Louise Allan, et al.
Pageof 57